Acasti Pharma reported $1.96M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acasti Pharma USD 1.96M 180K Sep/2025
Addus HomeCare USD 80.44M 1.95M Sep/2026
Amarin USD 18.97M 1.03M Dec/2025
Cassava Sciences USD 3.37M 521K Jun/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Option Care Health USD 177.64M 12.98M Sep/2026
Organigram Holdings CAD 26.51M 4.5M Jun/2026
Tilray USD 24.85M 1.7M Sep/2025